Highlights at ASCO 2023

ASCO 2023: Updates on Use of ESAs in Low-Risk MDS highlighting COMMANDS Clinical TrialПодробнее

Update from ASCO GI 2023 Upper GI cancer highlights podcast (SHORT)Подробнее

ASCO 2023: Use of Radiation after Complete Response in PMBCL highlighting the IELSG47 Clinical TrialПодробнее

Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua SabariПодробнее

ASCO 2023 HighlightsПодробнее

ASH 2023 CLL/Lymphoma Highlights – ALPINE, SEQUOIA, SWOG-S1826, POLARIX Update | Dr. Mazyar ShadmanПодробнее

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01Подробнее

ASCO 2023: Updates of Treatment of Low-risk MDS highlighting the IMerge Clinical TrialПодробнее

ASCO 2023: Updates on Use of ESAs in Low-Risk MDS highlighting COMMANDS Clinical TrialПодробнее

ASCO 2023: Updates on Treatment for Hodgkin’s Lymphoma highlighting SWOG 1826 Clinical TrialПодробнее

Breast Cancer Breakthroughs Highlights from ASCO 2023: SONIA TrialПодробнее

Highlights from ASCO 2023Подробнее

Breast Cancer Breakthroughs Highlights from ASCO 2023: HER3-DXd TrialПодробнее

Highlights ASCO 2023Подробнее

Breast Cancer Breakthroughs Highlights from ASCO 2023: PHERGAIN TrialПодробнее

Highlights ASCO-WCGI 2023Подробнее

ASCO Guideline Recommendation Highlights for Systemic Therapy for MelanomaПодробнее

Breast Cancer Breakthroughs Highlights from ASCO 2023: NATALEE TrialПодробнее

Evento científico: Atualizações e Highlights dos principais temas apresentados na ASCO 2023.Подробнее

ASCO 2023 - New Data Highlights Three Studies Showing The Impact Of Vitrakvi On Long-Term Efficacy &Подробнее